Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non–Small Cell Lung Cancer

PURPOSE: Histone deacetylase inhibitors (HDACis) are epigenetic regulators and used clinically for hematopoietic malignancies. Recently, HDACis have received attention as a factor that modulates the immune system. In this study, the role of histone deacetylase (HDAC) expression as a predictive marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hyun-Seock, Choi, Juwhan, Lee, Jinhwan, Lee, Sung Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016298/
https://www.ncbi.nlm.nih.gov/pubmed/34517693
http://dx.doi.org/10.4143/crt.2021.425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016298/
https://www.ncbi.nlm.nih.gov/pubmed/34517693
http://dx.doi.org/10.4143/crt.2021.425

Ejemplares similares